Literature DB >> 16680064

N-acetylcysteine prevents nitrosative stress-associated depression of blood pressure and heart rate in streptozotocin diabetic rats.

Prabhakara Reddy Nagareddy1, Zhengyuan Xia, Kathleen M MacLeod, John H McNeill.   

Abstract

Previous studies have indicated that cardiovascular abnormalities such as depressed blood pressure and heart rate occur in streptozotocin (STZ) diabetic rats. Chronic diabetes, which is associated with increased expression of inducible nitric oxide synthase (iNOS) and oxidative stress, may produce peroxynitrite/nitrotyrosine and cause nitrosative stress. We hypothesized that nitrosative stress causes cardiovascular depression in STZ diabetic rats and therefore can be corrected by reducing its formation. Control and STZ diabetic rats were treated orally for 9 weeks with N-acetylcysteine (NAC), an antioxidant and inhibitor of iNOS. At termination, the mean arterial blood pressure (MABP) and heart rate (HR) were measured in conscious rats. Nitrotyrosine and endothelial nitric oxide synthase (eNOS) and iNOS expression were assessed in the heart and mesenteric arteries by immunohistochemistry and Western blot experiments. Untreated diabetic rats showed depressed MABP and HR that was prevented by treatment with NAC. In untreated diabetic rats, levels of 15-F(2t)-isoprostane, an indicator of lipid peroxidation increased, whereas plasma nitric oxide and antioxidant concentrations decreased. Furthermore, decreased eNOS and increased iNOS expression were associated with elevated nitrosative stress in blood vessel and heart tissue of untreated diabetic rats. N-acetylcysteine treatment of diabetic rats not only restored the antioxidant capacity but also reduced the expression of iNOS and nitrotyrosine and normalized the expression of eNOS to that of control rats in heart and superior mesenteric arteries. The results suggest that nitrosative stress depress MABP and HR following diabetes. Further studies are required to elucidate the mechanisms involved in nitrosative stress mediated depression of blood pressure and heart rate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16680064     DOI: 10.1097/01.fjc.0000211744.93701.25

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  13 in total

Review 1.  Adiponectin: mechanisms and new therapeutic approaches for restoring diabetic heart sensitivity to ischemic post-conditioning.

Authors:  Tingting Wang; Shanglong Yao; Zhengyuan Xia; Michael G Irwin
Journal:  Front Med       Date:  2013-07-20       Impact factor: 4.592

2.  Aldose reductase mediates endotoxin-induced production of nitric oxide and cytotoxicity in murine macrophages.

Authors:  Kota V Ramana; Aramati B M Reddy; Ravinder Tammali; Satish K Srivastava
Journal:  Free Radic Biol Med       Date:  2007-01-24       Impact factor: 7.376

3.  Angiotensin II decreases nitric oxide synthase 3 expression via nitric oxide and superoxide in the thick ascending limb.

Authors:  Vanesa D Ramseyer; Jeffrey L Garvin
Journal:  Hypertension       Date:  2008-12-15       Impact factor: 10.190

4.  Role of mitogen-activated protein kinase cascades in inducible nitric oxide synthase expression by lipopolysaccharide in a rat Schwann cell line.

Authors:  Haibo Wang; Chun Cheng; Yongwei Qin; Shuqiong Niu; Shangfeng Gao; Xin Li; Tao Tao; Aiguo Shen
Journal:  Neurochem Res       Date:  2008-07-31       Impact factor: 3.996

5.  Enhancement of endothelial nitric oxide synthase production reverses vascular dysfunction and inflammation in the hindlimbs of a rat model of diabetes.

Authors:  A Riad; D Westermann; S Van Linthout; Z Mohr; S Uyulmaz; P M Becher; H Rütten; P Wohlfart; H Peters; H-P Schultheiss; C Tschöpe
Journal:  Diabetologia       Date:  2008-09-30       Impact factor: 10.122

6.  Dietary supplementation with vitamin E ameliorates cardiac failure in type I diabetic cardiomyopathy by suppressing myocardial generation of 8-iso-prostaglandin F2alpha and oxidized glutathione.

Authors:  Milton Hamblin; Holly M Smith; Michael F Hill
Journal:  J Card Fail       Date:  2007-12       Impact factor: 5.712

7.  Augmented cardiac formation of oxidatively-induced carbonylated proteins accompanies the increased functional severity of post-myocardial infarction heart failure in the setting of type 1 diabetes mellitus.

Authors:  Kathleen E Dennis; Salisha Hill; Kristie L Rose; Uchechukwu K A Sampson; Michael F Hill
Journal:  Cardiovasc Pathol       Date:  2013-04-06       Impact factor: 2.185

8.  Glyoxalase-1 overexpression reduces endothelial dysfunction and attenuates early renal impairment in a rat model of diabetes.

Authors:  Olaf Brouwers; Petra M G Niessen; Toshio Miyata; Jakob A Østergaard; Allan Flyvbjerg; Carine J Peutz-Kootstra; Jonas Sieber; Peter H Mundel; Michael Brownlee; Ben J A Janssen; Jo G R De Mey; Coen D A Stehouwer; Casper G Schalkwijk
Journal:  Diabetologia       Date:  2013-10-26       Impact factor: 10.122

9.  Selective inhibition of protein kinase C beta(2) attenuates inducible nitric oxide synthase-mediated cardiovascular abnormalities in streptozotocin-induced diabetic rats.

Authors:  Prabhakara Reddy Nagareddy; Hesham Soliman; Guorong Lin; Padmesh S Rajput; Ujendra Kumar; John H McNeill; Kathleen M MacLeod
Journal:  Diabetes       Date:  2009-07-08       Impact factor: 9.461

10.  Type 1 diabetes mellitus abrogates compensatory augmentation of myocardial neuregulin-1β/ErbB in response to myocardial infarction resulting in worsening heart failure.

Authors:  Oghenerukevwe Odiete; Ewa A Konik; Douglas B Sawyer; Michael F Hill
Journal:  Cardiovasc Diabetol       Date:  2013-03-27       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.